Medovate and JEB Technologies unite to drive medical device advances
They have created the enterprise to integrate management, unique skills sets and all-round expertise. The strategy is designed to accelerate the introduction of pioneering medical technologies that enhance patient safety and care – in the UK and worldwide.
Medovate is an award-winning medical device development company and JEB Technologies an established leader in end-to-end medical device design and manufacturing.
The companies are combining their strengths across the full medical device development pipeline – from concept design, product development and manufacturing, through to successful regulatory approvals and global market launches.
Medovate’s approach to developing technologies in collaboration with the NHS will be complemented by JEB’s extensive manufacturing experience – spanning over 50 years – in developing, manufacturing, and commercialising products globally.
Stuart Thomson, Vice-President of Business Development for Medovate, said: “This is a significant step forward for the medical device industry in the UK’s eastern region, leveraging our organisations’ collective strengths and expertise, along with our respective medical technology pipelines, to accelerate the development of innovative UK medical devices and launch them successfully around the world.
“Medovate’s experienced team will work seamlessly with JEB Technologies to drive innovation development which will positively impact healthcare globally.”
JEB Technologies’ portfolio includes recently launched prostate biopsy device Camprobe®, Transicap® and exciting further products currently in development.
Sean Licence, Vice-President of Operations for JEB commented: “Developing cutting-edge medical devices involves complex engineering challenges, regulatory requirements and market demands. By uniting Medovate’s clinician-inspired model with JEB Technologies’ worldwide manufacturing and design proficiency, we will drive innovation and strengthen our offering to both the medical technology industry and healthcare providers.”
